Tamoxifen: all 215 studies that test it
Page 3 of 3. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00002864Phase 3
- Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00002777Phase 3
- Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast CancerCompletedNCT00002720Phase 3
- Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast CancerCompletedNCT00002646Phase 3
- Tamoxifen for the Prevention of Breast Cancer in High-Risk WomenCompletedNCT00002644Phase 3
- Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsCompletedNCT00002608Phase 2
- Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00002582Phase 3
- Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast CancerCompletedNCT00002581Phase 3
- Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast CancerCompletedNCT00002580Phase 3
- Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast CancerCompletedNCT00002579Phase 3
- Tamoxifen in Treating Women With High-Risk Breast CancerCompletedNCT00002542Phase 3
- Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast CancerCompletedNCT00002529Phase 3
- Adjuvant Hormone Therapy in Treating Women With Operable Breast CancerStatus unknownNCT00002460Phase 3
- A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With OsteosarcomaCompletedNCT00001436Phase 1
- Tamoxifen StudyCompletedNCT00000529Phase 3